PP353 : AntiVEGF eye drop prevents recurrence in pterygium: a nsafe and novel approach

Dr.SNEHA KUMARI

Aim :To examine the efficacy of post-operative topical Bevacizumab drops in preventing recurrence of pterygium Design:Prospective, randomised, comparative,interventional study Participants : 25 primary pterygium cases were divided randomly into two groups .Group A autologus graft only and Group B :autologus graft with Bevacizumab drops (freshly prepared) Main outcome measures : Recurrence and postoperative complications Results :Recurrence rate of 39% and 30% were noted in A and B after mean follow up of 12 months which is statistically significant(p<0.05).Mean recurrence free period in group A was 9.3 months in 88% cases. Conclusions :Midterm results of topical Bevacizumab used post-operatively four times a day for seven days at the concentration of 6.25mg/ml are encouraging.Total dose of 1.25 mg per day was found to be safe and effective in preventing recurrence without any serious complications.